AC Immune SA (FRA:IMR)
Germany · Delayed Price · Currency is EUR 2.475
0.00 (0.00%)
Last updated: Dec 1, 2025, 8:10 AM CET
AC Immune Income Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 4.37 | 27.31 | 14.8 | 3.94 | - | 15.43 | Upgrade | |
Revenue Growth (YoY) | -89.33% | 84.51% | 276.14% | - | - | -86.03% | Upgrade |
Cost of Revenue | 61.6 | 62.57 | 54.61 | 60.34 | 62.28 | 59.49 | Upgrade |
Gross Profit | -57.23 | -35.26 | -39.81 | -56.4 | -62.28 | -44.06 | Upgrade |
Selling, General & Admin | 15.88 | 17.26 | 15.31 | 15.79 | 17.91 | 18.56 | Upgrade |
Other Operating Expenses | -0.04 | -0.14 | -1.49 | -1.34 | -1.18 | -1.35 | Upgrade |
Operating Expenses | 15.85 | 17.12 | 13.82 | 14.45 | 16.73 | 17.2 | Upgrade |
Operating Income | -73.08 | -52.38 | -53.62 | -70.85 | -79.01 | -61.26 | Upgrade |
Interest Expense | -0.18 | -0.13 | -0.18 | -0.36 | -0.58 | -0.18 | Upgrade |
Interest & Investment Income | 2.4 | 3.2 | 1.04 | 0.07 | 6.49 | 0.08 | Upgrade |
Currency Exchange Gain (Loss) | -0.55 | -1.6 | -1.47 | 0.39 | 0.11 | -0.56 | Upgrade |
EBT Excluding Unusual Items | -71.4 | -50.91 | -54.22 | -70.74 | -72.99 | -61.92 | Upgrade |
Pretax Income | -71.87 | -50.91 | -54.22 | -70.74 | -72.99 | -61.92 | Upgrade |
Income Tax Expense | 0 | 0 | 0.01 | 0.01 | 0 | - | Upgrade |
Net Income | -71.87 | -50.92 | -54.23 | -70.75 | -73 | -61.92 | Upgrade |
Net Income to Common | -71.87 | -50.92 | -54.23 | -70.75 | -73 | -61.92 | Upgrade |
Shares Outstanding (Basic) | 100 | 100 | 85 | 84 | 75 | 72 | Upgrade |
Shares Outstanding (Diluted) | 100 | 100 | 85 | 84 | 75 | 72 | Upgrade |
Shares Change (YoY) | 4.26% | 17.71% | 1.36% | 11.48% | 4.24% | 1.12% | Upgrade |
EPS (Basic) | -0.72 | -0.51 | -0.64 | -0.85 | -0.97 | -0.86 | Upgrade |
EPS (Diluted) | -0.72 | -0.51 | -0.64 | -0.85 | -0.97 | -0.86 | Upgrade |
Free Cash Flow | -47.7 | 65.27 | -61.21 | -74.81 | -68.32 | -61.22 | Upgrade |
Free Cash Flow Per Share | -0.47 | 0.66 | -0.72 | -0.90 | -0.91 | -0.85 | Upgrade |
Gross Margin | - | -129.12% | -268.94% | - | - | -285.50% | Upgrade |
Operating Margin | -1671.43% | -191.80% | -362.30% | -1800.43% | - | -396.99% | Upgrade |
Profit Margin | -1643.89% | -186.44% | -366.41% | -1798.04% | - | -401.28% | Upgrade |
Free Cash Flow Margin | -1091.10% | 238.99% | -413.55% | -1901.07% | - | -396.75% | Upgrade |
EBITDA | -71.65 | -50.89 | -51.95 | -69.05 | -77.11 | -59.73 | Upgrade |
EBITDA Margin | - | -186.36% | - | - | - | - | Upgrade |
D&A For EBITDA | 1.42 | 1.49 | 1.67 | 1.79 | 1.9 | 1.54 | Upgrade |
EBIT | -73.08 | -52.38 | -53.62 | -70.85 | -79.01 | -61.26 | Upgrade |
EBIT Margin | - | -191.80% | - | - | - | - | Upgrade |
Revenue as Reported | 4.37 | 27.31 | 14.8 | 3.94 | - | 15.43 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.